C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2004
12/14/2004	US6831161 For chromatography; genetic engineering; albumin-binding protein
12/14/2004	US6831062 Bacillus thuringiensis toxins with improved activity
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	US6830936 Miniaturization
12/14/2004	US6830924 For anticarcinogenic drugs; kits
12/14/2004	US6830921 Nucleotide sequences which code for the ACP gene
12/14/2004	US6830919 For ceramide metabolism/formation of fatty acid and sphingoid; genetic engineering; for treatment of metabolic disorders
12/14/2004	US6830913 ABCB9 transporter and uses thereof
12/14/2004	US6830908 Glycosyltransferase and DNA encoding the same
12/14/2004	US6830907 Mutants of Mycobacterium vaccae-derived formate dehydrogenase and uses thereof
12/14/2004	US6830903 Comprises culturing altered bacterial cells having increased amounts of NADPH; phosphoglucoisomerases; homologous recombination
12/14/2004	US6830901 Propionibacteruim vector
12/14/2004	US6830899 Method for the production of para-hydroxybenzoate in Pseudomonas mendocina
12/14/2004	US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004	CA2291929C Novel microorganisms, microbial symbionts, their culture methods, and methods for treating manganese-containing water using them
12/14/2004	CA2169355C Tumor suppressor protein prb2, related gene products, and dna encoding therefor
12/09/2004	WO2004107243A1 Method for designing dna codes used as information carrier
12/09/2004	WO2004106524A1 Protease, dna coding for the protease and process for producing the protease
12/09/2004	WO2004106520A1 Plant gene activation vector and utilization thereof
12/09/2004	WO2004106513A1 Host cells deficient for mismatch repair
12/09/2004	WO2004106510A1 Enzyme with xylanase activity at acidic ph
12/09/2004	WO2004105822A1 New product
12/09/2004	WO2004105810A1 Treatment of biological material containing living cells using a plasma generated by a gas discharge
12/09/2004	WO2004091505A3 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
12/09/2004	WO2004076615A3 Immunomodulating probiotic compounds
12/09/2004	WO2004069996A3 Bacteria and process for producing chemical compounds by said bacteria
12/09/2004	WO2004063360A3 Improved method for the production of vitamin b12
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040249178 Biological conjugates used for drug delivery; side effect reduction
12/09/2004	US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249134 Factor viii c2 domain variants
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249131 Mycobacterial sulfation pathway proteins and methods of use thereof
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248791 Insect g protein-coupled receptor genes and uses thereof
12/09/2004	US20040248786 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248280 Animal feed containing polypeptides
12/09/2004	US20040248279 Sporulation defective transgenic bacillus for use as bioreactors for generation of proteins useful in foodstuffs, drugs, cosmetics, detergents and fiber treatments
12/09/2004	US20040248278 Streptococcus expressing lymphocytic protein for use in prevention and treatment of insulin resistance, obesity, autism and attention deficit/hyperactivity disorders
12/09/2004	US20040248275 Forming biomasses of heterogenous planktonic bacteria via exposure to concanavalin a; monitoring efficacy of bactericides/microbiocides; bioremediation and degradation
12/09/2004	US20040248272 Heat-labile desoxyribonuclease I variants
12/09/2004	US20040248264 Nucleotide sequence coding phosphotransferase for use in the transformation and propagation of transgenic corynebacterium; fermentation of lysine for use in preparing nutrient broths, animal feeds and cosmetics
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248250 Method for modifying enzyme and oxidoreductive variant
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248248 Isolated human transporters proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/09/2004	US20040248247 Helix-loop-helix (BHLH) motif and a per-rrnt-sim homology domain (pas domain) (BHLH-PAS) protein for use in identifying modulators for diagnosis, prevention and treatment of retardation and nervous system disorders
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease
12/09/2004	US20040248238 Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant production
12/09/2004	US20040248236 Bacillus strain and antibiotic screening method
12/09/2004	US20040248224 Detection of antibodies to squalene in serum
12/09/2004	US20040248207 Sodium channel regulators and modulators
12/09/2004	US20040248202 Labeled chimeric membrane protein for use as tool in identifying modulators for treatment and prevention of viral infection and cell proliferative disorders
12/09/2004	US20040248180 Nucleotide sequences coding modified chromgenic and/or fluorescent protein for use as diagnostic indicators in genetic engineering
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040248166 Nucleotide sequences coding peptide receptor for use as tools in diagnosis, prevention and treatment of cancer, arthritis or viral infection
12/09/2004	US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof
12/09/2004	US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design
12/09/2004	US20040248133 Method for determining cell cycle position
12/09/2004	US20040248129 Neural polypeptide for use as tool in identifying modulators for controlling body weight; treating obesity
12/09/2004	US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004	US20040248119 Dna fragments containing gene having function relating to autonomous proliferation of plasmid
12/09/2004	US20040248115 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages
12/09/2004	US20040248101 Identification of novel antibacteria agents by screening the single-stranded DNA expression library
12/09/2004	US20040248083 Viral plasmid comprising heterologous or synthetic dimerisation sequences which promotes dimer formation of plasmid transcripts and prevents recombination between plasmid transcripts and another retrovirus present in genome; gene transfer tool; bioreactor
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/09/2004	US20040247620 Genetic transduction for improved exogenous gene expression of epothilones in a modified host cell
12/09/2004	US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004	US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247583 Capable of producing d-pseudoephedrine by acting on l-2-methylaminopropiophenone; a nucleic acid coding the enzyme, a microorganism producing the enzyme, and producing an optically active aminoalcohol using them
12/09/2004	US20040247581 Bacterial strains that adhere to intestinal gut (capability to adhere to the cell lines Caco-2 or Hep-2) and lowering the concentration of pathogenic peptides (measured as peptidase activity), used to treat behavioral or psychiatric disorders, such as autism, ADHD, mood disorders, and schizophrenia
12/09/2004	DE102004019852A1 New modified sarcosine oxidase, useful for assaying creatinine, e.g. for diagnosis of kidney disease, has improved stability under acidic conditions, also new DNA that encodes it
12/09/2004	CA2524454A1 Enzyme with xylanase activity at acidic ph
12/09/2004	CA2523977A1 New product
12/08/2004	EP1484415A2 Method of alleviating pest infestation in plants
12/08/2004	EP1484412A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/08/2004	EP1484410A1 Fermentation methods and genetically modified bacteria with increased substrate and byproduct uptake.
12/08/2004	EP1484407A1 Method of controlling ethanol production and mass production of lactic acid and transformant therefor
12/08/2004	EP1484406A1 Process for producing n-acetylneuraminic acid
12/08/2004	EP1484404A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1484398A1 Human glioma antigen originating in testis
12/08/2004	EP1484395A1 Transposon being functional in mammals
12/08/2004	EP1484392A1 Diacylglycerol acyltransferase genes, proteins and uses thereof
12/08/2004	EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth
12/08/2004	EP1484288A2 Process for purifying waste water that is polluted with MTBE or TAME by using the strain Mycobacterium Austroafricanum I-2562, which is fixed on a mineral support comprising perlite
12/08/2004	EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
12/08/2004	EP1483398A2 Method for producing riboflavin
12/08/2004	EP1483396A2 Wit 3.0, novel gene to control soft tissue wound healing
12/08/2004	EP1483393A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae

1 ... 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 ... 1489